Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares (BMGL) Revenue
Annual & quarterly revenue history · segment & region breakdown
BMGL · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBasel Medical Group Ltd Ordinary Shares trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Basel Medical Group Ltd Ordinary Shares receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Basel Medical Group Ltd Ordinary Shares reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Basel Medical Group Ltd Ordinary Shares's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BMGL revenue · 4 questionsBMGL's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Basel Medical Group Ltd Ordinary Shares SEC filings · GAAP · Basel Medical Group Ltd Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026